Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 31  |  Issue : 1  |  Page : 262-266

Theassociationof hypolipidemic agents with macular edema in diabetic maculopathy


1 Department of Ophthalmology, Faculty of Medicine, Menoufia University, Shebeen El-Kom, Egypt
2 Department of Ophthalmology, OphthalmologyHospital, Kafr El Sheikh, Egypt

Correspondence Address:
Heba A Abd El-Fatah
Ophthalmology Hospital, Kafr El Sheikh
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_535_16

Rights and Permissions

Objective Theaimof this study was to assess the effect of lipid-lowering agents on macular edema in patients with diabetic maculopathy guided by optical coherence tomography and fundus fluorescein angiography. Backgrounds The most threatening complication of diabetic retinopathy(DR) is diabetic macular edema.The risk factors for diabetic macular edema are largely similar to those for DR, but dyslipidemia appears to play a more significant role. Serum lipid level has a direct role in the development of macular edema. Lowering of serum lipids has shown a benefit on both proliferative disease and maculopathy besides their lipid-lowering effect. Independentof accompanying macular edema, the severity of retinal hard exudates at baseline was associated with decreased visual acuity. Patients and methods The study included 80patients with DR and hyperlipidemia; 50% of were undergoing treatment with antihyperlipidemic drugs(group I) and other 50% did not receive treatment(group II) (control group) at the Ophthalmology Clinic at the Menoufia University Hospital. Results In patients with DR and dyslipidemia, lowering of serum lipids has shown a benefit on both proliferative disease and maculopathy. Besides their lipid-lowering effect, there was a significant decrease in macular thickness measured using optical coherence tomography after 9 months of treatment with antihyperlipidemic drugs. Conclusion Dyslipidemia appears to play a direct role in the development of clinically significant macular edema. Lowering of serum lipids has shown a benefit on both proliferative DR and maculopathy, besides their lipid-lowering effect.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed432    
    Printed6    
    Emailed0    
    PDF Downloaded40    
    Comments [Add]    

Recommend this journal